IMMULITE Systems PSA
Siemens Healthcare Diagnostics, Inc. · Decision date Sep 22, 2026
What did the FDA decide?
The FDA record for P930027/S041 lists a 30-day notice for IMMULITE Systems PSA, with the stated purpose of moving manufacturing of a critical component within the same facility. The notice reason is Process Change - Manufacturer/Sterilizer/Packager/Supplier. The record does not name the component, the facility, or the manufacturing steps involved, so the scope of the change cannot be described beyond the field labels.
The identifier ties this supplement to the original PMA P930027, which covers total prostate specific antigen testing for detection of prostate cancer under product code MTF in Immunology, submitted by Siemens Healthcare Diagnostics, Inc. A supplement is not a new approval of the whole system, and a manufacturing notice is not an original PMA. The reported purpose of the move does not by itself establish safety or clinical effectiveness.
FDA approval order statement
to move manufacturing of a critical component within the same facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Immunology
- Decision date
- Sep 22, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P930027/S041
- Regulatory pathway
- PMA supplement
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Product code
- MTF
- Decision code
- OK30
- Decision date
- Sep 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer.
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Product code
- MTF
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P930027. Subsequent supplements may change the device or its indications.
FDA decision timeline
P930027 · Original PMA
IMMULITE SYSTEMS PSA & THIRD GENERATION PSA REAGENTS
P930027/S041 received
Application receipt date recorded by FDA.
P930027/S041 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P930027. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P930027
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Siemens Healthcare Diagnostics, Inc. | PMA approval | Sep 15, 1995 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Siemens Healthcare Diagnostics, Inc.
- Headquarters
- Not reported
- Brand website
- siemens-healthineers.com
- FDA applicant address
- Glyn Rhonwy, Llanberis, Gwynedd Ll55 4el, LL554EL
Sources and methodology
- Original FDA record: P930027/S041
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records